208 related articles for article (PubMed ID: 37022562)
1. Relation between ocular paraneoplastic syndromes and Immune Checkpoint Inhibitors (ICI): review of literature.
Casselman P; Jacob J; Schauwvlieghe PP
J Ophthalmic Inflamm Infect; 2023 Apr; 13(1):16. PubMed ID: 37022562
[TBL] [Abstract][Full Text] [Related]
2. Melanoma-associated retinopathy during pembrolizumab treatment probably controlled by intravitreal injections of dexamethasone.
Poujade L; Samaran Q; Mura F; Guillot B; Meunier I; Du-Thanh A
Doc Ophthalmol; 2021 Apr; 142(2):257-263. PubMed ID: 32975694
[TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic syndromes in ophthalmology.
Bussat A; Langner-Lemercier S; Salmon A; Mouriaux F
J Fr Ophtalmol; 2018 May; 41(5):e181-e185. PubMed ID: 29784239
[TBL] [Abstract][Full Text] [Related]
4. Neurological autoimmunity in melanoma patients: a comparison between those exposed and non-exposed to immune checkpoint inhibitors.
Vilaseca A; Farina A; Villagrán-García M; Pegat A; Benaiteau M; Ciano-Petersen NL; Do LD; Rogemond V; Gonçalves D; Psimaras D; Birzu C; Honnorat J; Joubert B
J Neurol; 2024 Jun; 271(6):3279-3290. PubMed ID: 38467790
[TBL] [Abstract][Full Text] [Related]
5. THE ROLE OF CHECKPOINT INHIBITORS IN PARANEOPLASTIC ACUTE EXUDATIVE POLYMORPHOUS VITELLIFORM MACULOPATHY: REPORT OF TWO CASES.
Kemels D; Ten Berge JCEM; Jacob J; Schauwvlieghe PP
Retin Cases Brief Rep; 2022 Sep; 16(5):614-618. PubMed ID: 32740323
[TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic ocular syndrome: a pandora's box of underlying malignancies.
Sarkar P; Mehtani A; Gandhi HC; Bhalla JS; Tapariya S
Eye (Lond); 2022 Jul; 36(7):1355-1367. PubMed ID: 34345027
[TBL] [Abstract][Full Text] [Related]
7. Ocular Paraneoplastic Syndromes.
Przeździecka-Dołyk J; Brzecka A; Ejma M; Misiuk-Hojło M; Torres Solis LF; Solís Herrera A; Somasundaram SG; Kirkland CE; Aliev G
Biomedicines; 2020 Nov; 8(11):. PubMed ID: 33182708
[TBL] [Abstract][Full Text] [Related]
8. [Paraneoplastic retinopathy and optic neuropathy].
Ikawa M; Kuriyama M
Brain Nerve; 2010 Apr; 62(4):371-6. PubMed ID: 20420177
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic vitelliform retinopathy associated with cutaneous or uveal melanoma and metastases.
Sotodeh M; Paridaens D; Keunen J; van Schooneveld M; Adamus G; Baarsma S
Klin Monbl Augenheilkd; 2005 Nov; 222(11):910-4. PubMed ID: 16308825
[TBL] [Abstract][Full Text] [Related]
10. Acute exudative polymorphous paraneoplastic vitelliform maculopathy (AEPPVM) associated with choroidal melanoma.
Gameiro Filho AR; Sturzeneker G; Rodriguez EEC; Maia A; Morales MC; Belfort RN
Int J Retina Vitreous; 2021 Apr; 7(1):27. PubMed ID: 33795031
[TBL] [Abstract][Full Text] [Related]
11. Encephalitis Induced by Immune Checkpoint Inhibitors: A Systematic Review.
Velasco R; Villagrán M; Jové M; Simó M; Vilariño N; Alemany M; Palmero R; Martínez-Villacampa MM; Nadal E; Bruna J
JAMA Neurol; 2021 Jul; 78(7):864-873. PubMed ID: 33720308
[TBL] [Abstract][Full Text] [Related]
12. ACUTE EXUDATIVE PARANEOPLASTIC POLYMORPHOUS VITELLIFORM MACULOPATHY DURING VEMURAFENIB AND PEMBROLIZUMAB TREATMENT FOR METASTATIC MELANOMA.
Sandhu HS; Kolomeyer AM; Lau MK; Shields CL; Schuchter LM; Nichols CW; Aleman TS
Retin Cases Brief Rep; 2019 Spring; 13(2):103-107. PubMed ID: 28614138
[TBL] [Abstract][Full Text] [Related]
13. [Paraneoplastic retinopathy].
Liu Y; Lei B
Zhonghua Yan Ke Za Zhi; 2012 Jul; 48(7):653-6. PubMed ID: 22943872
[TBL] [Abstract][Full Text] [Related]
14. [Paraneoplastic Syndromes in Ophthalmology (French version of the article)].
Bussat A; Langner-Lemercier S; Salmon A; Mouriaux F
J Fr Ophtalmol; 2018 Jun; 41(6):554-559. PubMed ID: 29891101
[TBL] [Abstract][Full Text] [Related]
15. Autoantibody against transient receptor potential M1 cation channels of retinal ON bipolar cells in paraneoplastic vitelliform retinopathy.
Wang Y; Abu-Asab MS; Li W; Aronow ME; Singh AD; Chan CC
BMC Ophthalmol; 2012 Nov; 12():56. PubMed ID: 23148706
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic vitelliform retinopathy in a patient with treated choroidal melanoma.
Williams SL; McDonald HR; Jumper JM; Fu AD; Lujan BJ; Cunningham ET; Johnson RN
Retin Cases Brief Rep; 2014; 8(4):269-72. PubMed ID: 25372525
[TBL] [Abstract][Full Text] [Related]
17. Paraneoplastic vitelliform retinopathy: clinicopathologic correlation and review of the literature.
Aronow ME; Adamus G; Abu-Asab M; Wang Y; Chan CC; Zakov ZN; Singh AD
Surv Ophthalmol; 2012 Nov; 57(6):558-64. PubMed ID: 22784677
[TBL] [Abstract][Full Text] [Related]
18. Exudative Polymorphous Vitelliform Retinopathy: Importance of Early Recognition of the Condition in Patients with Metastatic Melanoma.
Lincoff N; Nadeem M; Younus Z; Thirkill CE
Ophthalmol Ther; 2016 Jun; 5(1):121-7. PubMed ID: 26892474
[TBL] [Abstract][Full Text] [Related]
19. Paraneoplastic Neurological Syndromes and Beyond Emerging With the Introduction of Immune Checkpoint Inhibitor Cancer Immunotherapy.
Valencia-Sanchez C; Zekeridou A
Front Neurol; 2021; 12():642800. PubMed ID: 33897597
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
